Abbott’s Interferon-free Hep C Combo With Ribavirin Has High Cure Rates
This article was originally published in The Pink Sheet Daily
Executive Summary
Abbott revealed more data from its Phase II Aviator program Nov. 10 during a press conference at the American Association for the Study of Liver Disease meeting showing high cure rates in some difficult patient populations and a 100% cure rate for the easier to treat genotype 1 subgroup.